| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.07 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.07 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.094 | 0.08 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.08 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.08 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.061 | 0.09 |